A detailed history of Janiczek Wealth Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 40 shares of NTRA stock, worth $6,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 40 -0.0%
Holding current value
$6,740
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$37.55 - $62.64 $1,239 - $2,067
-33 Reduced 45.21%
40 $2,000
Q2 2023

Jul 11, 2023

SELL
$47.08 - $55.16 $14,594 - $17,099
-310 Reduced 80.94%
73 $3,000
Q1 2023

Apr 21, 2023

BUY
$36.57 - $58.29 $12,543 - $19,993
343 Added 857.5%
383 $21,000
Q4 2022

Jan 20, 2023

BUY
$34.17 - $47.91 $1,366 - $1,916
40 New
40 $0
Q4 2021

Feb 02, 2022

SELL
$86.26 - $119.0 $948 - $1,309
-11 Reduced 64.71%
6 $1,000
Q3 2021

Oct 19, 2021

BUY
$100.17 - $126.36 $1,702 - $2,148
17 New
17 $2,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.